Community Research and Development Information Service - CORDIS

Results 1 - 10 of 62
Order by: Results/page:
12 3 4 5 6 7 > 
Screening for Chronic Kidney Disease (CKD)  among Older People across Europe (SCOPE)
ID: 634869
Start date: 2015-05-01, End date: 2019-04-30
Chronic kidney disease (CKD) is an important public health problem worldwide, especially in older people. Indeed, population aging in industrialized countries is accompanied by an increase in the prevalence of CKD and its complications. Although its prevalence and the...
Programme: H2020-EU.3.1.2.
Record Number: 193309
Last updated on: 2017-09-11
Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe
ID: 634453
Start date: 2015-06-01, End date: 2018-05-31
Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single...
Programme: H2020-EU.3.1.2.
Record Number: 193289
Last updated on: 2017-09-11
Integrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive Compounds
ID: 634880
Start date: 2015-05-01, End date: 2019-04-30
A large body of evidence supports associations between exposure to anthropogenic chemicals and endocrine disruptive effects, leading to disorders in humans and wildlife. Based on the scientific documentation it is beyond doubt that endocrine disrupting chemicals (EDCs) are of...
Programme: H2020-EU.3.1.1.
Record Number: 193310
Last updated on: 2017-09-11
Understanding the dynamic determinants of glucose homeostasis and social capability to promote Healthy and active aging
ID: 633595
Start date: 2015-04-01, End date: 2019-03-31
The Gluco-Psychosocial Axis (GPA) concerns the interplay of factors determining glucose metabolism and insulin sensitivity and the neuroendocrine response resulting from exposure to psychosocial stress. A sub-optimal GPA influences the development of type 2 diabetes and...
Programme: H2020-EU.3.1.1.
Record Number: 193247
Last updated on: 2017-09-11
Ageing Trajectories of Health: Longitudinal Opportunities and Synergies
ID: 635316
Start date: 2015-05-01, End date: 2020-04-30
The objective of the ATHLOS Project is to achieve a better understanding of ageing by identifying patterns of healthy ageing pathways or trajectories, the determinants of those patterns, the critical points in time when changes in trajectories are produced, and to propose...
Programme: H2020-EU.3.1.1.
Record Number: 193326
Last updated on: 2017-08-26
Chair/bedside diagnosis of oral and respiratory tract infections, and identification of antibiotic resistances for personalised monitoring and treatment
ID: 633780
Start date: 2015-06-01, End date: 2019-05-31
The project aims at diagnosing oral and respiratory tract infections (RTIs) using a fully integrated, automated and user-friendly platform for physicians’ offices, schools, elderly care units, community settings, etc. Oral diseases (periodontitis, caries) will be detected...
Programme: H2020-EU.3.1.
Record Number: 193255
Last updated on: 2017-08-22
Novel Stromal Cell Therapy for Diabetic Kidney Disease
ID: 634086
Start date: 2015-05-01, End date: 2019-04-30
Type 2 diabetes will affect >500 million adults by 2040 and its secondary complications will generate enormous socioeconomic costs - in particular, diabetic kidney disease (DKD), which is already the most common cause of chronic kidney disease. DKD is associated with greatly...
Programme: H2020-EU.3.1.
Record Number: 193269
Last updated on: 2017-08-22
Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
ID: 633413
Start date: 2015-09-01, End date: 2019-08-31
Amyotrophic Lateral Sclerosis (ALS) is a fatal degenerative disorder of the brain and spinal cord affecting some 40,000 individuals in Europe, causing 11,000 deaths each year. Our pioneering work on riluzole showed that it is possible to modify ALS progression but all...
Programme: H2020-EU.3.1.
Record Number: 193232
Last updated on: 2017-08-22
Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication
ID: 633545
Start date: 2015-05-01, End date: 2017-12-31
Cystic fibrosis (CF) is a progressive life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene leading to a dysfunctional CFTR protein. The disease affects over 70,000 patients worldwide and while many mutations are...
Programme: H2020-EU.3.1.
Record Number: 193242
Last updated on: 2017-08-22
Sustainable tailored integrated care for older people in Europe
ID: 634144
Start date: 2015-04-01, End date: 2019-03-31
The overall aims of SUSTAIN are twofold: 1. to improve established integrated care initiatives for older people living at home with multiple health and social care needs, ensuring they are patient-centred, prevention oriented, efficient, resilient to crises, safe and...
Programme: H2020-EU.3.1.
Record Number: 193274
Last updated on: 2017-08-22
12 3 4 5 6 7 > 
List retrieved on: 2017-12-18
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top